Company news
TempraMed Technologies Ltd. news in 2025
TempraMed Technologies Ltd.'s news releases, calls and decks from 2025, newest first.
TempraMed Deepens Asian Market Penetration with Expanded Distribution Partnership and Meaningful Commercial Order in South Korea
December 31, 2025
TempraMed Launches New Product, VIVI Cap Smart, Expanding Its Portfolio to Include a Digital Health Offering
December 26, 2025
TempraMed Expands U.S. Manufacturing Capacity with New Production Facility in Florida
December 17, 2025
TempraMed Strengthens Global Intellectual Property Position with Grant of South Korean Patent
December 15, 2025
TempraMed Appoints Leading Diabetes Researcher Professor Dr. Lutz Heinemann to its Scientific Advisory Board
December 10, 2025
TempraMed Announces Strategic Agreement with Maccabi Healthcare Services, a Leading HMO with over 2.8 Million Patients
December 8, 2025
TempraMed Expands European Footprint with Distribution Partnership in Netherlands, Belgium, and Luxembourg
December 5, 2025
TempraMed Technologies Ltd. (CNSX: VIVI) Exclusive Commercial Distribution Agreement with Turkish Medical Device Supplier
December 3, 2025
TempraMed Signs Exclusive Commercial Distribution Agreement with Leading Distributor to the Turkish Market
December 2, 2025
TempraMed Signs Exclusive Distribution Agreement with Leading Consumer Health Distributor in Israel
November 26, 2025
TempraMed Announces Frankfurt Stock Exchange Listing and Corporate Awareness Agreement
November 18, 2025
TempraMed to Support Beyond Type 1's Beyond Type Run Team at the 2025 TCS New York City Marathon
October 27, 2025
TempraMed Announces Private Placement of up to C$2.5 Million
October 21, 2025
Canadian Securities Exchange Welcomes Listing of TempraMed Technologies Ltd.
October 15, 2025